What is TGEN's health score?

TECOGEN INC. (TGEN) has a TradeApes health score of 37 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TGEN's estimated fair value?

Based on our 5-year discounted cash flow model, TECOGEN INC.'s estimated fair value is $1.95 per share, representing a -71.8% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is TGEN undervalued or overvalued?

Our model currently rates TGEN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for TGEN... Refresh in a moment for the full analysis.

TECOGEN INC. (TGEN)

Technology Overvalued low weak

$6.9

Updated: 2026-06-05

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

38 Weak

Relative Value

40 Weak

Capital Allocation

35 Weak

Risk

55 Mixed

Est. Fair Value $1.95

DCF Upside -71.8%

Sector Rank #2161 of 7656

Key Findings

+ Solid revenue growth — sales up 8–20% year over year

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.